Skip to search formSkip to main contentSkip to account menu

tazifylline

Known as: 1H-Purine-2,6-dione, 3,7-dihydro-7-(2-hydroxy-3-(4-(3-(phenylthio)propyl)-1-piperazinyl)propyl)-1,3-dimethyl-, tazifylline dihydrochloride 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

RS 49014

Broader (1)

Theophylline
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
The reducing effects of tazifylline on histamine-induced bronchoconstriction in atopic asthmatics.
Percentage reductions in the peak flow rates to a standardized number of histamine inhalations were compared after 7 days of… 
1989
1989
Multiple-dose pharmacokinetics of the new H1-receptor antagonist tazifylline in healthy volunteers.
The multiple-dose pharmacokinetics of the new H1-receptor antagonist, tazifylline, were investigated in healthy volunteers. From… 
1988
1988
Antiallergic effects of the new histamine H1-receptor antagonist tazifylline in healthy atopic and non-atopic subjects.
Single oral doses (5, 10 and 15 mg) of the new H1-receptor antagonist 3,7-dihydro-7-[2-hydroxy-3-[4-[3-phenylthio) propyl]-1… 
1988
1988
174 Antiallergic effects of a new histamine H 1 antagonist tazifylline
1986
1986
Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
3,7-Dihydro-7-[2-hydroxy-3-[4-[3-(phenylthio) propyl]-1-piperazinyl]propyl]-1,3-dimethyl-1H-purine-2,6-dione dihydrochloride… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)